• chevron_right

      Why the Tavistock gender identity clinic was forced to shut ... and what happens next

      news.movim.eu / TheGuardian · Sunday, 31 March, 2024 - 11:00 · 1 minute

    The clinic at the heart of a heated national debate formally closes this weekend. The journalist who told the inside story of its practice reflects on those it leaves behind

    It was a report in this newspaper that sparked my real interest in Gids – that made me ask “what’s going on?”. It was November 2018 and the article, by Jamie Doward, revealed that the Gender Identity Development Service, to use its full title, was undertaking a review. The details were scarce, but a senior member of staff had claimed that the service was “failing to examine fully the psychological and social reasons behind young people’s desire to change gender”.

    In the week that Gids’s 35-year history has finally ended , I’ve been thinking about that time. How it set the scene of what would unfold over the next few years, and how things could have been so different. What if NHS England had acted when it saw a report of those concerns? It didn’t, and the service remained open for another six years. A service which referred children for puberty-blocking drugs, without robust data to support that this was beneficial, and that shut down the concerns of a growing number of its own staff.

    Continue reading...
    • chevron_right

      Ireland’s smoking ban 20 years on: how an unheralded civil servant triumphed against big tobacco

      news.movim.eu / TheGuardian · Friday, 29 March, 2024 - 05:00

    Tom Power led an alliance that brought about the pioneering health initiative which has since been adopted by more than 70 countries – and has saved countless lives

    Exactly 20 years ago an Irish civil servant named Tom Power won a remarkable battle against the tobacco industry when Ireland enacted the world’s first ban on smoking in bars, restaurants and workplaces.

    TV crews from Japan, the US and elsewhere flocked to Dublin to record the events of 29 March 2004. No one knew what would happen. Would smokers revolt? Would pubs flout the law? Would a bold experiment go up in smoke?

    Continue reading...
    • chevron_right

      Obese children twice as likely to develop multiple sclerosis, study suggests

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 23:01


    Swedish researchers say inflammation caused by obesity is likely to increase risk of developing conditions such as MS

    Children who are obese may face more than double the risk of developing multiple sclerosis as adults, a study suggests.

    MS can affect the brain and spinal cord, causing a range of potential symptoms including problems with vision, arm or leg movement, sensation or balance. It is a lifelong condition that can sometimes cause serious disability.

    Continue reading...
    • chevron_right

      ‘People assume you’re crazy for doing it’: the Melbourne clinic infecting healthy patients

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 23:00

    Australia’s first unit dedicated to human challenge trials for novel vaccines and treatments has opened. But what are the ethics of infecting healthy people – and who would do it?

    Green plants, cool tones, casually placed scatter cushions: this living room in East Melbourne could belong to – or at least, be rented by – any millennial. The squeaky corridor floors are a giveaway, though; along with the beds on wheels.

    This isn’t a real estate opportunity, but Doherty Clinical Trials (DCT) – Australia’s first unit dedicated to human challenge studies, where trial participants are given a dose of an infectious disease in a controlled setting. An offshoot of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, it opens on Monday – a breeding ground, its proprietors hope, for discoveries that may redefine the future of disease.

    Continue reading...
    • chevron_right

      Wishing John Crace and the NHS a good recovery | Letters

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 18:24

    Readers respond to an article by the Guardian’s parliamentary sketch writer about his heart attack, and share similar stories of their own

    Thank you to John Crace for this article ( ‘Is this how I die?’ John Crace on his terrifying heart attack, 21 March ). It has allowed me to start the process of accepting that although my two heart attacks on Christmas Day 2022 were mild and sorted by some stents, they were still serious. Surrounded by men on my ward who were recovering from, or waiting for, various heart bypass procedures, I felt almost like a fraud – after all, a stent is at the lower end of the scale, or so I convinced myself.

    I have laughed off the concern of loved ones and friends, and dined out on a good story that involved me thinking I had a bad chest infection on the day, accounting for my chest pains and breathlessness and symptoms that in general did not conform to my view of what a heart attack should be like.

    Continue reading...
    • chevron_right

      Dementia is not a living death – I’m very much alive | Letter

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 18:24

    Willy Gilder thinks the Alzheimer’s Society latest ad campaign is a mistake and would like to see it withdrawn

    The chief executive of the Alzheimer’s Society has sought to justify its new ad campaign, The Long Goodbye , by saying that it “tells the unvarnished truth about the devastation caused by dementia”. It isn’t a truth that I, as a person with Alzheimer’s disease, recognise. The ad shows a family mourning their mum, and saying that she died several times in advance of her actual death as she realised that she could no longer cook a family meal, or take part in social activities.

    This idea of dementia being a “living death” reinforces the most negative stereotypes of my condition, and contravenes guidance for journalists drawn up by the society itself six years ago. I share a dementia diagnosis with the star of Die Hard, Bruce Willis. I prefer to try to Live Well, or as well as I am able. It dismays me that the country’s leading dementia charity seems to want to reinforce the stigma surrounding brain disease.

    Continue reading...
    • chevron_right

      Super gonorrhea rate quickly triples in China, now 40x higher than US

      news.movim.eu / ArsTechnica · Thursday, 28 March, 2024 - 18:12 · 1 minute

    A billboard from the AIDS Healthcare Foundation is seen on Sunset Boulevard in Hollywood, California, on May 29, 2018, warning of a drug-resistant gonorrhea.

    Enlarge / A billboard from the AIDS Healthcare Foundation is seen on Sunset Boulevard in Hollywood, California, on May 29, 2018, warning of a drug-resistant gonorrhea. (credit: Getty | )

    Health officials have long warned that gonorrhea is becoming more and more resistant to all the antibiotic drugs we have to fight it. Last year, the US reached a grim landmark : For the first time, two unrelated people in Massachusetts were found to have gonorrhea infections with complete or reduced susceptibility to every drug in our arsenal, including the frontline drug ceftriaxone. Luckily, they were still able to be cured with high-dose injections of ceftriaxone. But, as the US Centers for Disease Control and Prevention bluntly notes: "Little now stands between us and untreatable gonorrhea."

    If public health alarm bells could somehow hit a higher pitch, a study published Thursday from researchers in China would certainly accomplish it. The study surveyed gonorrhea bacterial isolates— Neisseria gonorrhoeae —from around the country and found that the prevalence of ceftriaxone-resistant isolates nearly tripled between 2017 and 2021. Ceftriaxone-resistant strains made up roughly 8 percent of the nearly 3,000 bacterial isolates collected from gonorrhea infections in 2022. That's up from just under 3 percent in 2017. The study appears in the CDC's Morbidity and Mortality Weekly Report.

    While those single-digit percentages may seem low, compared to other countries they're extremely high. In the US, for instance, the prevalence of ceftriaxone-resistant strains never went above 0.2 percent between 2017 and 2021 , according to the CDC. In Canada, ceftriaxone-resistance was stable at 0.6 percent between 2017 and 2021. The United Kingdom had a prevalence of 0.21 percent in 2022.

    Read 6 remaining paragraphs | Comments

    • chevron_right

      Girl, 10, left inoperable after planned NHS surgery cancelled seven times

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 16:34


    Eva Tennent, whose operations were scheduled in Edinburgh, has Rett syndrome and advanced scoliosis

    A 10-year-old girl’s spinal condition has become inoperable after her planned surgery was cancelled seven times in six months, her mother has claimed.

    Eva Tennent suffers from Rett syndrome, a rare genetic disorder that affects brain development, and has advanced scoliosis that causes her spine to twist and curve to the side.

    Continue reading...
    • chevron_right

      Cost of private Covid jabs risks widening health inequalities, experts warn

      news.movim.eu / TheGuardian · Thursday, 28 March, 2024 - 16:00

    Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

    Experts and patient groups have warned that the high cost of private Covid vaccinations could exacerbate health inequalities and leave those more at risk from the virus without a vital line of defence.

    Both high street chain Boots and pharmacies that partner with the company Pharmadoctor are now offering Covid jabs to those not eligible for a free vaccination through the NHS, with the former charging almost £100 for the Pfizer/BioNTech jab.

    Continue reading...